United States Securities and Exchange Commission
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )
AXIS RESEARCH & TECHNOLOGIES, INC.
formerly
NOCHE GROTTO ACQUISITION CORPORATION
(Name of Issuer)
Common Stock
(Title of Class of Securities)
None
(CUSIP Number)
16662 Hale Avenue
Irvine, CA 92606
949-288-6007
-------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
5/22/2015
-----------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f)
or 240.13d-1(g), check the following box. [ ]
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
======================================================================
CUSIP NO. None 13D Page 2
1. Name of Reporting Persons: Nick Moran
-------------------------------------------------------------------
2. Check the appropriate box if a member of a group:
(a)
(b)
-------------------------------------------------------------------
3. SEC use only
-------------------------------------------------------------------
4. Sourt of Funds PF
-------------------------------------------------------------------
5. Check if disclosure of legal proceeding is required pursuant
to Itmes 2(d) or 2(e) [ ]
-------------------------------------------------------------------
6. Citizenship or place of organization: USA
-------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. Sole Voting Power: 22,048,000 shares common diretly owned
-------------------------------------------------------------------
8. Shared Voting Power: None
-------------------------------------------------------------------
9. Sole Dispositive Power: 22,048,000 shares
-------------------------------------------------------------------
10. Shared Dispositive Power: None
-------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
22,048,000 shares common
-------------------------------------------------------------------
12. Check if The Aggregate Amount in Row 11 Excludes Certain Shares.
/ / [ ]
-------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row 11
93.8%
(based on 23,500,000 shares outstanding)
-------------------------------------------------------------------
14. Type of Reporting Person: Individual
======================================================================
CUSIP NO. None 13D Page 3
Item 1 Security and Issuer
(a) Name of Issuer: Axis Research & Technologies, Inc.
(b) Address of Issuer's Principal Executive Offices:
16662 Hale Avenue, Irvine, CA 92606
(c) Common stock, $0.0001 par value per share
-------------------------------------------------------------------
Item 2 Identity and Background
(a) Name of Person Filing: Nick Moran
(b) Address of Principal Business or, if none, Residence:
16662 Hale Avenue, Irvine, CA 92606
(c) Principal occupation or employment: Businessman, founder
of Primal Fitness Centers.
(d) During the past five years, Mr. Moran has not been
convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors).
(e) During the last five years, Mr. Moran has not been a
party to a civil proceeding of a judicial or administrative
body of competent jurisdiction which as a result of such
proceeding was or is subject to a judgment, decree, or
final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state
securities laws or finding any violation with respect to
such laws.
(f) Citizenship: USA
-------------------------------------------------------------------
Item 3. Source and Amount of Funds or Other Consideration
In May Mr. Moran received 3,000,000 as part of a change
of control at par. In June he was issued 16,970,000
shares at par and in July received 2,078,000 shares as
part of a stock for stock exchange.
-------------------------------------------------------------------
Item 4. Purpose of transaction
The shares were issued as part of a change in control of
the Company and as a stock for stock exchange in development
of the Company as a multi-purpose bioskilss facilities
supporting medical research and technology development.
-------------------------------------------------------------------
Item 5. Interest in Securities of Issuer
(a) As of the filing date of the Schedule 13D, Mr. Moran
(i) is the beneficial owner and
(ii) has sole power to vote
(iii) 22,048,000 shares ofcommon stock which represents approximately
93.8% of the 23,500,000 shares of common stock deemed to be
outstanding pursuant to Rule 13d-1(j).
(b) The responses to Items 7-11 of the cover page of this Schedule 13D are
incorporated herein.
(c) Except as set forth or incorporated herein, no other transaction in the
common stock has been effected during the past 60 days.
(d) Not applicable.
(e) Not applicable.
-------------------------------------------------------------------
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Not applicable.
-------------------------------------------------------------------
Item 7. Materials to Be Filed as Exhibits
Not applicable.
-------------------------------------------------------------------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Dated: October 19, 2015
/s/ Nick Moran
--------------------------------------
Nick Moran